PDCD1 and neoplasm: To characterize genomic ITH within the tumor specimen progressing during PD-1 inhibitor treatment (“on-PD-1 inhibitor” tumor), we performed deep targeted DNA sequencing for a panel of 265 cancer-related genes (Supplementary Data 2) of DNA from 41 tumor sub-regions.